United Therapeutics Stock
Price
Target price
€347.80
€347.80
33.300%
86.8
33.300%
€370.00
02.09.25 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
United Therapeutics dominated the market today, gaining €86.80 (33.300%).
With 22 Buy predictions and not a single Sell prediction United Therapeutics is an absolute favorite of our community.
With a target price of 370 € there is a slightly positive potential of 6.38% for United Therapeutics compared to the current price of 347.8 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 33.300% | -0.950% | 2.356% | -20.760% | -23.548% | 14.644% | 189.667% |
| Ironwood Pharmaceuticals | 0.000% | 1.852% | 65.414% | -75.771% | -73.810% | -89.743% | -86.905% |
| Novocure Ltd | 1.150% | 4.020% | 7.048% | -41.256% | -64.011% | -86.771% | -85.260% |
| Iovance Biotherapeutics Inc. | -1.840% | -11.024% | -16.295% | -81.594% | -71.868% | -81.782% | -93.176% |
Comments
United Therapeutics (NASDAQ:UTHR) had its price target raised by analysts at Jefferies Financial Group Inc. from $432.00 to $564.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Corporation (NASDAQ: UTHR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Corporation (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $385.00 to $415.00. They now have a "buy" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat